Form 4: Teladoc Health CEO Charles Divita III Acquires Restricted Stock Units
SEC Form 4 Filing
Teladoc Health's CEO, Charles Divita III, reports the acquisition of 469,924 restricted stock units (RSUs) on June 10, 2024, according to a Form 4 filing with the SEC.
Summary
- On June 10, 2024, Charles Divita III, the CEO of Teladoc Health, acquired 469,924 restricted stock units (RSUs).
- These RSUs represent a contingent right to receive one share of Teladoc Health common stock each.
- The vesting schedule for these RSUs is as follows: one-third vests on June 10, 2025, and the remaining units vest in eight substantially equal quarterly installments thereafter.
- The transaction was reported in a Form 4 filing with the Securities and Exchange Commission (SEC) on June 12, 2024.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The acquisition of RSUs by the CEO suggests confidence in the company, but it's a routine transaction.
Positives
- The acquisition of restricted stock units by the CEO could be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The document does not contain specific forward-looking statements, but the vesting schedule of the RSUs suggests a multi-year commitment from the CEO.
Industry Context
This type of equity compensation is common in the healthcare technology industry to align executive incentives with shareholder value and long-term company performance.
Comparison to Industry Standards
- Granting restricted stock units to executives is a standard practice among publicly traded companies, including those in the telehealth sector.
- Companies like Amwell and Accolade also use equity-based compensation to incentivize their leadership teams.
- The vesting schedule of one-third after one year followed by quarterly installments is a typical arrangement.
Stakeholder Impact
- Shareholders may view the CEO's acquisition of RSUs as a positive sign, aligning his interests with theirs.
- Employees may see this as a sign of stability and confidence in the company's leadership.
Key Dates
| Date | Description |
|---|---|
| 06/10/2024 | Date of transaction: Charles Divita III acquired 469,924 restricted stock units. |
| 06/10/2025 | Vesting start date: One-third of the restricted stock units vest. |
| 06/12/2024 | Date of Form 4 filing with the SEC. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.